These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9202565)

  • 21. Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery.
    Nelson CJ; Hsiao W; Balk E; Narus J; Tal R; Bennett NE; Mulhall JP
    J Sex Med; 2013 Oct; 10(10):2559-65. PubMed ID: 23898886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study.
    Claro Jde A; de Aboim JE; Maríngolo M; Andrade E; Aguiar W; Nogueira M; Nardozza Júnior A; Srougi M
    Sao Paulo Med J; 2001 Jul; 119(4):135-7. PubMed ID: 11500786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
    Polito M; d'Anzeo G; Conti A; Muzzonigro G
    BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases: a study of satisfaction and safety.
    Limoge JP; Olins E; Henderson D; Donatucci CF
    J Urol; 1996 Apr; 155(4):1276-9. PubMed ID: 8632551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
    Chao R; Clowers DE
    Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining intracavernous injection and external vacuum as treatment for erectile dysfunction.
    Chen J; Godschalk MF; Katz PG; Mulligan T
    J Urol; 1995 May; 153(5):1476-7. PubMed ID: 7714970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erectile dysfunction in spinal cord injury: a cost-utility analysis.
    Mittmann N; Craven BC; Gordon M; MacMillan DH; Hassouna M; Raynard W; Kaiser A; Lanctôt LK; Tarride JE
    J Rehabil Med; 2005 Nov; 37(6):358-64. PubMed ID: 16287667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximisation of the erectile response in the investigation of impotence.
    Mills RD; Sethia KK
    Int J Impot Res; 1999 Feb; 11(1):29-32; discussion 33-4. PubMed ID: 10098951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The female factor: predicting compliance with a post-prostatectomy erectile preservation program.
    Moskovic DJ; Mohamed O; Sathyamoorthy K; Miles BJ; Link RE; Lipshultz LI; Khera M
    J Sex Med; 2010 Nov; 7(11):3659-65. PubMed ID: 20819141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical effectiveness of self-injection and external vacuum devices in the treatment of erectile dysfunction: a six-month comparison.
    Turner LA; Althof SE
    Psychiatr Med; 1992; 10(2):283-93. PubMed ID: 1377397
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
    Bechara A; Casabé A; Chéliz G; Romano S; Rey H; Fredotovich N
    J Urol; 1997 Jun; 157(6):2132-4. PubMed ID: 9146599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rehabilitation of the cavernous smooth muscle in patients with organic erectile dysfunction.
    Salem H; Mostafa T
    Andrologia; 2012 Apr; 44(2):125-9. PubMed ID: 21592173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.
    Abdallah HM
    Int Urol Nephrol; 1998; 30(5):617-20. PubMed ID: 9934808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracavernous self-injection therapy for the treatment of erectile dysfunction.
    Chiang HS; Wen TC; Wu CC; Chiang WH
    J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E1 therapy for impotence, comparison with papaverine.
    Earle CM; Keogh EJ; Wisniewski ZS; Tulloch AG; Lord DJ; Watters GR; Glatthaar C
    J Urol; 1990 Jan; 143(1):57-9. PubMed ID: 2294263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.
    Richter S; Vardi Y; Ringel A; Shalev M; Nissenkorn I
    Int J Impot Res; 2001 Jun; 13(3):172-5. PubMed ID: 11525316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.